Therefore, we looked for changes in the expression of these CSC markers in both breast cancer cell lines overexpressing MAP17, observing significantly increased mRNA levels of all these stem cell transcripts (Fig. 4a, Supplementary Fig. 2C). The gene discussed is PDZK1IP1; the disease is breast cancer.